Position in BMY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$73,600,502
-$3,554,242 QoQ
Shares Held
1,277,343
+0.4% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#127
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 3%
None 41%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $2,652,531,465 across 15 Drug Manufacturers - General names. BMY ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,519,569 | $634,024,342 | |
| 2 | JNJ |
Johnson & Johnson
|
2,173,861 | $552,095,477 | |
| 3 | LLY |
ELI LILLY & Co
|
400,653 | $480,555,266 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,308,510 | $296,643,534 | |
| 5 | NVS |
Novartis AG
|
968,701 | $151,814,820 | |
| 6 | AZN |
Astrazeneca PLC
|
797,497 | $151,221,380 | |
| 7 | AMGN |
Amgen Inc
|
394,190 | $142,744,081 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
1,277,343 | $73,600,502 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,600,502 | 1,277,343 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $77,154,744 | 1,272,131 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $64,844,348 | 1,202,157 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $58,244,935 | 1,291,462 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $61,058,639 | 1,319,046 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $96,261,918 | 1,578,323 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $90,334,803 | 1,597,150 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $79,513,254 | 1,536,785 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $64,432,007 | 1,551,457 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $89,867,947 | 1,657,163 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $81,080,214 | 1,580,203 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $134,129,568 | 2,310,985 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $181,373,773 | 2,836,181 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $201,706,307 | 2,910,205 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $215,752,219 | 2,998,641 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $218,115,207 | 3,068,156 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $258,964,629 | 3,363,177 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $221,896,322 | 3,038,427 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $187,256,501 | 3,003,312 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $185,835,395 | 3,140,703 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $210,975,594 | 3,157,372 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $210,478,954 | 3,334,056 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $198,337,388 | 3,197,443 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $196,025,034 | 3,251,369 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $213,997,540 | 3,639,414 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $196,702,334 | 3,528,926 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||